Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Patient Educ Couns. 2018 Dec 12;102(5):842–849. doi: 10.1016/j.pec.2018.12.009

Table 1.

Prognostic tools included (N = 222).

Characteristics N (%)
Website
FCCC 54 (24%)
QxMD 39 (18%)
Lerner 31 (14%)
MSK 24 (11%)
KCI 16 (7%)
MD Anderson 12 (5%)
MAASTRO 11 (5%)
CancerMath 9 (4%)
Other 26 (12%)
Country Developed
USA 207 (93%)
Europe 13 (6%)
Unknown 2 (1%)
Year developed
Pre-2012 (2007 to 2011) 59 (27%)
2012 onwards 14 (6%)
No Year Provided 149 (67%)
Type of Cancer
Prostate 48 (22%)
Breast 24 (11%)
Kidney 23 (10%)
Blood 22 (10%)
Bladder 11 (5%)
Lung 11 (5%)
Colon 8 (4%)
Other Cancers 75 (3%)

FCCC: Fox Chase Cancer Center.

MSK: Memorial Sloan Kettering.

KCI: Kinetic Concepts Inc.

MAASTRO: Maastricht Radiation Oncology.